… The doses of UVA1 used for our patients with acute GVHD were based on our experience
in the treatment of chronic GVHD with medium dose UVA1 (50–60 J/cm 2 /treatment). Optimal …

… skin type, NB UVB dosage was increased with 0.1 to 0.2 J/cm 2 . Maximum NB UVB dose was
considered 1.3 J/cm 2 for skin … armamentarium of sclerotic skin diseases. The introduction …

… immune-mediated and autoimmune diseases. Although numerous … The efficacy of IVIg in
certain diseases has been proven in … with IVIg therapy for skin diseases and discusses current …

… medium-dose UVA1 therapy for the different skin diseases. In earlier studies, patients were
often treated with higher doses … skin diseases improved in our study with medium-dose UVA1 …

… autoimmune disorders, including autoimmune blistering skin diseases (2, 3). Rituximab …
disease relapse. Autoimmune blistering skin diseases are a group of heterogeneous skin …

… -mediated autoimmune diseases, which manifest with bullae and erosions on the skin and
… of blisters and erosions in the mouth, pharynx, and skin. Until the advent of steroid treatment, …

… dose (LD) (10-30 J/cm 2 ) or moderate/medium dose (MD) (40-70 J/cm 2 ). The high output,
high-dose (… Another classification is based on the administered cumulative dose. HD is then …

… or intimal hyperplasia and fibrosis of small and medium-sized blood vessels in the dermis
and … kidney, hepatic disease, hyperphosphatemia and the use of high doses of recombinant …

… The nearly missing correlation between inoculation dose and manifestation of clinical disease
… Since we diluted the viral stock in the same medium that was also used for propagation of …

… safety of medium doses of prednisone in BP. This is why we determined the population of
patients with BP who could most benefit from this treatment using thresholds in the BPDAI and …